3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Tuberous Sclerosis
1
Smoldering Multiple Myeloma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Monoclonal Gammopathy of Undetermined Significance
1
Lymphangioleiomyomatosis
1
Lung Neoplasms
1
Disease
1
Interventions
Peripheral Blood Stem Cell Transplantation
4
Epoetin Alfa
3
Darbepoetin alfa
3
Cyclophosphamide
3
liposomal amphotericin B
2
fludarabine phosphate
2
Microarray Analysis
2
Methylprednisolone
2
Interferon-alpha
2
In Situ Hybridization, Fluorescence
2
Filgrastim
2
Cytogenetic Analysis
2
Cyclosporine
2
Caspofungin
2
Bortezomib
2
Antilymphocyte Serum
2
tanespimycin
1
siltuximab
1
pyroxamide
1
piperine
1
ibrutinib
1
ferrous sulfate
1
ferric gluconate
1
aldesleukin
1
Whole-Body Irradiation
1
Watchful Waiting
1
Urination
1
Topotecan
1
Therapeutics
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Monoclonal Gammopathy of Undetermined Significance
×
Urination
×
Clear all
NCT03951220
2025-08-19
LOOMIS
Oxford University Hospitals NHS Trust
Completed
67 enrolled
24 charts